Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

D. A. Vallera, B. J. Stish, Y. Shu, H. Chen, A. Saluja, D. J. Buchsbaum, S. M. Vickers

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model'. Together they form a unique fingerprint.

Medicine & Life Sciences